Dyne Therapeutics Inc
Statements
Cash Flow
Dyne Therapeutics Inc (DYN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -130 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 15 | Q4 15 | Q1 16 | Q2 16 | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 323 | -208 | 191 | 126 | 332 | 27 | 149 | 81 | 271 | 84 | -2.4 | -2.4 | -3.0 | -4.0 | -7.3 | -7.3 | -12 | -20 | -18 | -46 | -27 | -28 | -51 | -31 | -43 | -29 | -47 | -56 | -51 | -35 | -79 | -55 | -75 | -84 | -106 | -95 | -91 | -112 | -145 | -130 | -478 | |
| 165 | 219 | 195 | 172 | 181 | 218 | 231 | 225 | 204 | 207 | 0.0 | 0.0 | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.3 | 0.3 | 0.4 | 0.5 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.6 | 0.4 | 0.4 | 0.4 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.6 | 0.6 | 2.1 | |
| – | 28 | – | – | – | 31 | – | – | – | 44 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 2.2 | 4.2 | 3.7 | 4.2 | 3.6 | 6.0 | 4.5 | 3.0 | 3.8 | 3.8 | 4.6 | 4.7 | 4.9 | 5.7 | 20 | 6.7 | 8.7 | 10 | 13 | 11 | 11 | 11 | 13 | 15 | 50 | |
| 78 | -58 | -83 | 659 | 202 | -110 | -308 | 140 | 162 | 14 | – | – | 2.4 | – | 0.1 | 0.2 | 2.5 | 4.2 | 4.1 | 4.9 | 4.3 | 6.0 | 4.6 | 4.6 | 3.3 | 4.1 | 4.6 | 4.6 | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -156 | -686 | 106 | -124 | 285 | 274 | 36 | 343 | -1,284 | -100 | -0.2 | -0.2 | 0.4 | 1.2 | 0.4 | 1.3 | -0.6 | 4.1 | 2.2 | -21 | 11 | 17 | -22 | 16 | -5.2 | 5.2 | -7.9 | 4.2 | 4.5 | 26 | -33 | 4.2 | 14 | -5.1 | -3.6 | 5.6 | 5.9 | -11 | -38 | 33 | -10 | |
| 69 | 104 | 65 | 159 | 35 | 67 | 31 | 31 | 0.0 | 224 | 0.1 | 0.1 | 0.7 | 0.7 | 0.2 | 0.1 | 0.2 | 0.7 | 0.0 | 0.7 | 0.9 | 2.0 | 1.4 | 0.3 | 0.9 | 0.5 | 0.2 | 0.3 | 0.2 | 0.1 | 0.2 | 0.9 | 0.3 | 1.1 | 1.0 | 0.1 | 19 | 0.5 | 0.2 | 1.5 | 21 | |
| -43 | -95 | -57 | -2,221 | -2.0 | 133 | -3,292 | -54 | 575 | 12 | -0.1 | -0.1 | -0.7 | -0.7 | -0.2 | -0.1 | -0.2 | -45 | -128 | -6.4 | -2.8 | -0.2 | -2.1 | 18 | 52 | 19 | 27 | 17 | 13 | 26 | -180 | 11 | -19 | -16 | 1.5 | 6.8 | -38 | 1.0 | -2.4 | -4.8 | -44 | |
| 5.0 | 6.0 | 5.0 | 6.0 | 5.0 | 6.0 | 5.0 | 6.0 | 5.0 | 6.0 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 584 | -123 | -821 | -321 | 1,142 | – | -467 | 20 | -166 | 613 | – | 20 | – | 20 | – | 2.0 | 382 | 0.0 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 140 | -53 | 198 | 2,080 | -1.0 | 148 | 425 | – | 1,322 | -2,643 | – | – | 5.0 | – | 9.9 | 5.0 | 0.0 | -10 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.0 | 99 | 0.0 | 49 | 6.2 | 57 | 113 | |
| -57 | -126 | 182 | 2,416 | -14 | 158 | -228 | -47 | -680 | -344 | 10.0 | 10.0 | 0.0 | 20 | 12 | 0.0 | 380 | -11 | 157 | 0.0 | 0.5 | 0.1 | 0.0 | 0.1 | 0.1 | 37 | 29 | 25 | 0.5 | 0.1 | 408 | 380 | 18 | 3.6 | 141 | 101 | 217 | 431 | 7.1 | 58 | 713 | |
| 223 | -429 | 316 | 321 | 316 | 318 | -3,371 | -20 | 166 | -248 | 7.5 | 23 | -5.3 | -3.1 | 4.4 | -7.4 | 368 | -76 | 10 | -53 | -29 | -28 | -53 | -12 | 8.9 | 27 | 9.0 | -14 | -37 | -8.7 | 150 | 336 | -76 | -97 | 37 | 13 | 89 | 320 | -140 | -77 | 191 | |
| 254 | -312 | 126 | -33 | 297 | -40 | 118 | 112 | 271 | -140 | -2.5 | -2.5 | -3.7 | -4.8 | -7.5 | -7.4 | -12 | -21 | -18 | -47 | -28 | -30 | -52 | -31 | -44 | -30 | -47 | -56 | -51 | -35 | -79 | -56 | -75 | -85 | -107 | -95 | -110 | -112 | -145 | -132 | -499 |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.